Cardinal Health, Inc.
Location
Ohio
Founded
1979-02-28
Website
Risk Signals
3281 news mentions monitored
Industry Context
This company is tracked across risk categories, including those related to its sector (e.g., Medical, Dental, and Hospital Equipment and Supplies, Drugs, Drug Proprietaries, and Druggists' Sundries, Management Services), including supply chain integrity, ESG practices, labor disputes, and regulatory compliance.
Filter risk signals by topic
Select a theme below to explore the company’s news mentions in specific risk areas.
Recent Articles about Cardinal Health, Inc.
Live alerts from global media, monitored by Business Radar
2024-09-06 (topclassactions.com)
McKesson, Cardinal, Cencora to pay $300M settlement over role in opioid epidemic
Three of the country’s largest drug distributors have reached a $300 million class action settlement over allegations they contributed to the opioid crisis, Reuters reports.
Read more
2024-02-28 (jaxdailyrecord.com)
$60 million Project Bobcat is The Anderson-DuBose Co. of Ohio
Legislation at City Council confirms the name while a regulatory application identifies a site in Westlake Industrial Park.
Read more
2024-02-19 (fox28spokane.com)
Bill addressing opioid crisis in tribal communities moves through Washington legislature | FOX 28 Spokane
OLYMPIA, Wash.- A policy which would direct funds to opioid addiction treatment and prevention in tribal communities has passed the Washington Senate. The bill, SB 6099, would direct$ 7.75 million in annual funds to tribal governments from a McKesson Corp., Cardinal Health Inc., and
Read more
2023-10-06 (amgreatness.com)
Congress Must Stop Tangoing with Opioid Pushers
When lawmakers want to pass legislation, they usually do two things: 1) find the warmest, fuzziest frontmen to call into hearings and 2) slap some catchy acronym on it like the H.O.P.E. Act...
Read more
2023-09-30 (owler.com)
Owler Reports - Cardinal Health, Inc.: Cardinal Health's revenue changed from $205.01B in Jun 2023 to $210.17B in Sep 2023
Cardinal Health’s Trailing Twelve Months revenue changed from $205.01B in Jun 2023 to $210.17B in Sep 2023 increasing 2.5% in this time period.
Read more
2023-08-19 (sinembargo.mx)
1
"In 2022, Walmart, Walgreens and CVS Pharmacy were ordered to pay $650 million, to just two Ohio counties, for damage caused by the opioid epidemic."
Read more
2023-07-18 (forextv.com)
Amarin Appoints Patrick Holt as President and Chief Executive Officer
DUBLIN, Ireland and BRIDGEWATER, N.J., July 18, 2023 (GLOBE NEWSWIRE) — Amarin Corporation plc (NASDAQ: AMRN) today announced that the Company’s Board of Directors has appointed Patrick Holt as President and Chief Executive Officer and as a member of the Board of Directors, effective immediately.
Read more
2023-06-28 (centerforbiosimilars.com)
The Age of Adalimumab Is Upon Us: How Stakeholders Can Prepare
The Center for Biosimilars® provides an updated look on the adalimumab biosimilars that are coming down the US pipeline as well as what stakeholders need to know and how they can prepare ahead of the US launch of 8 adalimumab biosimilars in July 2023.
Read more
2023-03-02 (wionews.com)
Pharmaceutical firms win opioid trial in Georgia court on suit filed by victims
In a first-ever lawsuit filed by victims of the opioid epidemic, and brought on to trial, a Georgia court gave its verdict in favour of pharmaceutical companies. The individual plaintiffs claimed that the medicine distributors Cardinal Health Inc( CAH.N), McKesson Corp( MCK.N) and JM Smith Corp,
Read more
2023-02-12 (healtheconomics.com)
Real World Evidence Archives - HealthEconomics.com
RWE, HEOR, and Market Access Content for Industry Professionals
Read more
2023-01-18 (woub.org)
West Virginia announces an $83 million opioid settlement with Walgreens - WOUB Public Media
CHARLESTON, W.Va. (AP) — West Virginia has settled for $83 million with Walgreens for the pharmacy store chain’s role in perpetuating the opioid crisis in the U.S. state with the... Read More
Read more
2023-01-03 (reuters.com)
Public nuisance law can cover product sales, profs tell 4th Circ.
Six law professors on Tuesday urged a federal appeals court to take an expansive view of public nuisance law as it considers whether to revive a lawsuit by a West Virginia city and county against the top U.S. drug distributors over their role in the opioid crisis.
Read more